ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male Volunteers

NCT01483911 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

RSV Infection

Interventions

BIOLOGICAL: ALX-0171
BIOLOGICAL: Placebo

Sponsor

Ablynx, a Sanofi company